11-[(8R,9S,13S,14S)-3-hydroxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-16-yl]-N-(2-pyridin-2-ylethyl)undecanamide

C36H50N2O3 — CID 91038491

IUPAC11-[(8R,9S,13S,14S)-3-hydroxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-16-yl]-N-(2-pyridin-2-ylethyl)undecanamide
SMILESC[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC(CCCCCCCCCCC(=O)NCCc1ccccn1)C2=O
InChIInChI=1S/C36H50N2O3/c1-36-21-19-31-30-18-16-29(39)24-26(30)15-17-32(31)33(36)25-27(35(36)41)12-8-6-4-2-3-5-7-9-14-34(40)38-23-20-28-13-10-11-22-37-28/h10-11,13,16,18,22,24,27,31-33,39H,2-9,12,14-15,17,19-21,23,25H2,1H3,(H,38,40)/t27?,31-,32-,33+,36+/m1/s1
InChIKeyTZVKDJHWJSYRGA-SHVRABGUSA-N
MW558.81 g/mol
LogP7.70
Rot. Bonds14

About 11-[(8R,9S,13S,14S)-3-hydroxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-16-yl]-N-(2-pyridin-2-ylethyl)undecanamide

11-[(8R,9S,13S,14S)-3-hydroxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-16-yl]-N-(2-pyridin-2-ylethyl)undecanamide (PubChem CID 91038491) has the molecular formula C36H50N2O3 and a molecular weight of 558.81 g/mol. Its IUPAC name is 11-[(8R,9S,13S,14S)-3-hydroxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-16-yl]-N-(2-pyridin-2-ylethyl)undecanamide.

Molecular Properties

Compound Name11-[(8R,9S,13S,14S)-3-hydroxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-16-yl]-N-(2-pyridin-2-ylethyl)undecanamide
PubChem CID91038491
Molecular FormulaC36H50N2O3
Molecular Weight558.81 g/mol
Exact Mass558.38
IUPAC Name11-[(8R,9S,13S,14S)-3-hydroxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-16-yl]-N-(2-pyridin-2-ylethyl)undecanamide
SMILESC[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC(CCCCCCCCCCC(=O)NCCc1ccccn1)C2=O
InChIInChI=1S/C36H50N2O3/c1-36-21-19-31-30-18-16-29(39)24-26(30)15-17-32(31)33(36)25-27(35(36)41)12-8-6-4-2-3-5-7-9-14-34(40)38-23-20-28-13-10-11-22-37-28/h10-11,13,16,18,22,24,27,31-33,39H,2-9,12,14-15,17,19-21,23,25H2,1H3,(H,38,40)/t27?,31-,32-,33+,36+/m1/s1
InChIKeyTZVKDJHWJSYRGA-SHVRABGUSA-N
XLogP7.70
TPSA79.29 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds14
Heavy Atoms41
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500558.81
LogP ≤ 57.70
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 11-[(8R,9S,13S,14S)-3-hydroxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-16-yl]-N-(2-pyridin-2-ylethyl)undecanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 11-[(8R,9S,13S,14S)-3-hydroxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-16-yl]-N-(2-pyridin-2-ylethyl)undecanamide?
The IUPAC name of 11-[(8R,9S,13S,14S)-3-hydroxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-16-yl]-N-(2-pyridin-2-ylethyl)undecanamide (CID 91038491) is 11-[(8R,9S,13S,14S)-3-hydroxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-16-yl]-N-(2-pyridin-2-ylethyl)undecanamide.
What is the SMILES notation for 11-[(8R,9S,13S,14S)-3-hydroxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-16-yl]-N-(2-pyridin-2-ylethyl)undecanamide?
The canonical SMILES for 11-[(8R,9S,13S,14S)-3-hydroxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-16-yl]-N-(2-pyridin-2-ylethyl)undecanamide is C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC(CCCCCCCCCCC(=O)NCCc1ccccn1)C2=O.
What is the InChIKey of 11-[(8R,9S,13S,14S)-3-hydroxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-16-yl]-N-(2-pyridin-2-ylethyl)undecanamide?
The InChIKey is TZVKDJHWJSYRGA-SHVRABGUSA-N. The full InChI is InChI=1S/C36H50N2O3/c1-36-21-19-31-30-18-16-29(39)24-26(30)15-17-32(31)33(36)25-27(35(36)41)12-8-6-4-2-3-5-7-9-14-34(40)38-23-20-28-13-10-11-22-37-28/h10-11,13,16,18,22,24,27,31-33,39H,2-9,12,14-15,17,19-21,23,25H2,1H3,(H,38,40)/t27?,31-,32-,33+,36+/m1/s1.
What are the key properties of 11-[(8R,9S,13S,14S)-3-hydroxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-16-yl]-N-(2-pyridin-2-ylethyl)undecanamide?
11-[(8R,9S,13S,14S)-3-hydroxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-16-yl]-N-(2-pyridin-2-ylethyl)undecanamide has a molecular weight of 558.81 g/mol, XLogP of 7.70, 14 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 11-[(8R,9S,13S,14S)-3-hydroxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-16-yl]-N-(2-pyridin-2-ylethyl)undecanamide is sourced from PubChem (CID 91038491), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).